STAT3 LOF mutations have been observed to be closely associated with a reduced proportion of Th17 cells (less than 0.3% of CD4+ T cells), in contrast to atopic dermatitis patients with unaffected STAT3 who generally exhibit significantly elevated levels of Th17 cells (31). The gene discussed is STAT3; the disease is atopic eczema.